Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs"

Drug Saf. 2018 Dec;41(12):1419-1421. doi: 10.1007/s40264-018-0726-3.

Authors

Courtney M Suggs¹, Robert L Levin², Andrew D Mosholder², Richard S Swain², Liang Zhao²

Affiliations

¹ US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA. [email protected].
² US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.

PMID: 30232739
DOI: 10.1007/s40264-018-0726-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Central Nervous System Agents
Drugs, Generic
Retrospective Studies
Suicidal Ideation*
Suicide*

Substances

Central Nervous System Agents
Drugs, Generic